Current status: 1036 hESC lines, 6489 hiPSC lines, and 156 clinical studies, and 2338 certificates
Monthly statistic from Oct 1, 2024
Posted on October 1, 2024
| total lines | 7525 |
| hESC lines | 1036 |
| hiPSC lines | 6489 |
| derivation countries | 50 |
| projects | 306 |
| providers | 932 |
| clinical studies | 156 |
| subclones | 3054 |
| certificates | 2338 |
| cell line certificates | 2192 |
| project certificates | 146 |